Summary
This study was designed to investigate the biologic and molecular basis of the aggressive behavior of high-grade post-thymic T-cell malignancies. Freshly frozen tumor tissues from (1) human T-cell leukemia/lymphoma virus type I (HTLV-I)-positive adult T-cell lymphoma (ATL) (7 cases), (2) HTLV-I-negative aggressive T-cell lymphoma (12 cases), and (3) HTLV-I-negative nonaggressive T-cell lymphoma (11 cases) were studied for the expression of several growth-related genes or proliferation antigens including interleukin-2 receptor (IL-2R), Ki-67, transforming growth factor-β (TGF-β), topoisomerase, and the multidrug resistance (MDR) gene by immunohistochemistry and Northern blot hybridization. Our results showed that tumor cells associated with HTLV-I and anaplastic morphology had an enhanced expression of Ki-67, TGF-β, and topoisomerase, as compared to nonaggressive T-cell lymphoma. The expression of IL-2R was limited to ATL and one Ki-1 lymphoma. The MDR gene was frequently expressed in ATL, but only infrequently in other, HTLV-I-negative, malignancies. Clinical progression or relapse was associated with the expression of MDR, in addition to an increased expression of Ki-67. We therefore conclude that the aggressive clinical behavior of high-grade T-cell lymphoma may result mainly from the high proliferative activity of tumor cells, but the association with HTLV-I and clinical relapse is further complicated by the development of drug resistance.
Supported by a research grant from the National Science Council, Taiwan, R.O.C. (NSC 78-0412-B002-162).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Jaffe ES. Pathologic and clinical spectrum of post-thymic T-cell malignancies. Cancer Invest 1984; 2: 413–26.
Suchi T, Lennert K, Tu LY, Kikuchi M, Sato E, Stansfeld AG, Feller EC. Histopatholoty and immunohistochemistry of peripheral T-cell lymphomas: A proposal for their classification. J Clin Pathol 1987; 40: 995–1015.
Su IJ, Wang CW, Cheng AL et al. Characterization of the spectrum of postthymic T-cell malignancies in Taiwan — A clinico-pathologic study of HTLV-1-positive and HTLV-1-negative cases. Cancer 1988; 61: 2060–70.
Cheng AL, Chen YC, Wang CH et al. Direct comparisons of peripheral T cell lymphoma with diffuse B cell lymphoma of comparabel histologic grades. Is PTCL a unique entity of lymphoma which warrants separate considerations. J Clin Oncol 1989; 7: 715–23.
Su IJ, Kadin M. Expression of growth factor/receptor genes in postthymic T cell malignancies. Am J Pathol 1989; 135: 43945.
Hall PA, Crocker J, Watts A, Stansfeld AG. A comparison of nucleolar organizer region staining and Ki-67 immunostaining in non-Hodgkin’s lymphoma. Histopathology 1988; 12: 37381.
Uemura T, Yanagida M. Isolation of type I and II DNA topoisomerase mutants from fission yeast: single and double mutants show different phenotypes in cell growth and chromatin organization. EMBO J. 1984; 3: 1737–44.
Weinstein RS, Kuszak JR, Kluskens LF, Coon JS. P-glycoproteins in pathology. The multidrug resistance gene family in humans. Human Pathol 1990; 21: 34–49.
Gerdes J, Dallenbach F, Lennert K, Stein H. Growth fractions in malignant non-Hodgkin’s lymphomas as determined in situ with the monoclonal antibody Ki67. Haematol. Oncol. 1984b; 2: 365–71.
Tandau G, Mirambeau G, Lavenot C, der Garabedian A, Vermeersch J, and Duguet M. DNA topoisomerase activities in concanavalin A-stimulated lymphocytes. FEBS Lett. 1984; 176: 431–5.
Armitage JO, Greer JP, Levine AM et al. Peripheral T cell lymphoma. Cancer 1989; 63: 158–63.
Fojo AT, Ueda K, Slaman DJ et al. Expression of a multidrugresistance gene in human tumors and tissues. Proc Natl Acad Sci USA 1987; 84: 3004–8.
Cairo MS, Siegel S, Anas N et al. Clinical trial of continuous infusion verapamil, bolus vinblastine, and continuous infusion VP-16 in drug-resistant pediatric tumors. Cancer Res 1989; 49: 1063–6.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Su, IJ., Chang, IC., Cheng, AL. (1991). Expression of growth-related genes and drug-resistance genes in HTLV-I-positive and HTLV-I-negative post-thymic T-cell malignancies. In: Ultmann, J.E., Samuels, B.L. (eds) Annals of Oncology. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-7305-4_24
Download citation
DOI: https://doi.org/10.1007/978-1-4899-7305-4_24
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4899-7294-1
Online ISBN: 978-1-4899-7305-4
eBook Packages: Springer Book Archive